Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |